Login to Your Account



AAAS

New Drug Delivery Approaches Critical to SiRNA Comeback

By Nuala Moran
Staff Writer

Wednesday, February 22, 2012

VANCOUVER, British Columbia – After the initial hype and some eye-watering investments, big pharma has abandoned the field of silent interfering RNA (siRNA) in the face of seemingly insuperable problems in getting those constructs to their targets.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription